High adenosine and deoxyadenosine concentrations in mononuclear cells of hemodialyzed patients

Journal of the American Society of Nephrology

Volumn 12, Issue 8, 2001, Pages 1721-1728

  Sampol, J ^a   Dussol, B ^a   Fenouillet, E ^a   Capo, C ^a   Mege, J L ^a   Halimi, G ^a   Bechis, G ^a   Brunet, P ^a   Rochat, H ^a   Berland, Y ^a   Guieu, R ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DEOXYADENOSINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HEMODIALYSIS; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; KIDNEY FAILURE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0034924211     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Host defenses and infectious complications in maintenance hemodialysis patients
2. Long term dialysis and cellular immunity: A critical survey
3. The immune system in end stage renal disease
4. Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: A model for immunodeficiency disease
5. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleosides phosphorylase deficiency
6. Deoxyadenosine blockade of G0 to G1 transition in lymphocytes: Possible involvement of protein kinases
7. Adenosine and hemodialysis in humans
8. Role of adenosine in dialysis-induced hypotension
9. Cardiovascular effects of adenosine in man: Possible clinical implications
10. Transport and metabolism of adenosine in human erythrocytes: Effects of transport inhibitors and regulation by phosphate
11. Characterization of equilibrative and concentrative Na+ dependent (cif) nucleoside transport in acute promyelocytic leukemia NB4 cells
12. Peripheral blood mononuclear cell adenosine deaminase activity in renal allograft recipients
13. Direct association of adenosine deaminase with a T cell activation antigen CD26
14. The extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation, in thymocytes by adenosine under conditions of inhibited, adenosine deaminase
15. Evidence for control of adenosine metabolism in rat oxidative skeletal muscle by changes in pH
16. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation
17. Purine nucleoside kinases in human T and B lymphoblasts
18. Adenosine metabolism during phorbol myristate acetate-mediated induction of HL-60 cell differentiation: Changes in expression pattern of adenosine kinase, adenosine deaminase, and 5′ nucleotidase
19. Regulation of deoxyadenosine and nucleoside analog phosphorylation by human placental adenosine kinase
20. Inhibition of adenosine kinase during oxygen-glucose deprivation in rat cortical neuronal cultures
21. Adenosine kinase inhibitors augment release of adenosine from spinal cord slices
22. The importance of adenosine deaminase for lymphocyte development and function
23. Adenosine deaminase deficiency
24. Purinogenic immunodeficiency diseases: Selective toxicity of deoxyribonucleosides for T cells
25. Gamma-interferon induced by S. aureus protein A augments natural killing and ADCC
26. Presence of preactivated T cells in hemodialyzed patients: Their possible role in altered immunity
27. Hemodialysis with cuprophane membrane modulates interleukin 2 receptor expression
28. Use of HPLC to measure circulating adenosine levels in migrainous patients
29. Development of an HPLC/diode array detector method for the determination of human plasma adenosine concentrations
30. Colorimetric method
31. Determination of adenosine kinase activity by high-pressure liquid chromatography
32. Effects of dialyzable leucocyte extracts (DLE) and inosine on stimulated lymphocytes
33. Uremic toxins and adenosine deaminase activity
34. Interactions between cyclosporine A and adenosine in kidney transplant recipients
35. Effects of hemodialysis on activation of lymphocytes: Analysis by an in vitro dialysis model
36. Surface expression of adenosine deaminase in mitogen-stimulated lymphocytes
37. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule
38. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase
39. The effect of deoxyadenosine plus deoxycoformycin on replicative and repair synthesis of DNA in human lymphoblasts and isolated nuclei
40. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes
41. 2′deoxycoformycin and deoxyadenosine affect IL2 production and IL2 receptor expression of human T cell
42. Apoptosis by 2-chloro-2′-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells
43. Apoptosis induced by modified ribonucleosides in human cell culture systems
44. Induction of apoptosis by 2-chloro-2′deoxyadenosine (2-CdA) alone and in combination with othercytotoxic drugs: Synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantrone
45. Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines
46. Characterization of adenosine binding to human CD26 on T cells and its biological role in immune response
47. Pathways for the degradation of Purines and Pyrimidine nucleotides
48. Inosine 5′ monophosphate dehydrogenase is a rate determining factor for p53-dependent growth regulation